About
Technology
Issues
FAQ
Links
Official Page
Neutrophil–lymphocyte ratio predicts early outcomes in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: a multicenter analysis
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.